0001140361-23-054299.txt : 20231121
0001140361-23-054299.hdr.sgml : 20231121
20231121213013
ACCESSION NUMBER: 0001140361-23-054299
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20231121
DATE AS OF CHANGE: 20231121
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Roivant Sciences Ltd.
CENTRAL INDEX KEY: 0001635088
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981173944
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-40782
FILM NUMBER: 231429777
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE, 2 CHURCH STREET
CITY: HAMILTON HM11
STATE: D0
ZIP: HM11
BUSINESS PHONE: 441-295-5950
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Venker Eric
CENTRAL INDEX KEY: 0001801917
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O ROIVANT SCIENCES, INC.
STREET 2: 320 WEST 37TH STREET, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
144
1
primary_doc.xml
144
0001801917
XXXXXXXX
LIVE
0001635088
Roivant Sciences Ltd.
001-40782
7th Floor
50 Broadway
London
X0
SW1H 0DB
44 207 400 3347
Eric Venker
President & COO
Common shares, $0.0000000341740141 par value per share (???Common Shares???)
E*TRADE FINANCIAL CORPORATION
3 EDISON DRIVE
ALPHARETTA
GA
30005
28936
254636.8
803921356
11/21/2023
Nasdaq
Common Shares
11/20/2023
Restricted Stock Units granted under the Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan
Roivant Sciences Ltd.
N
28936
11/20/2023
N/A
N
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
08/22/2023
16105
174417.15
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
09/01/2023
14763
175612.86
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
09/05/2023
73275
873311.45
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
09/06/2023
5926
70233.61
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
09/08/2023
106430
1297381.7
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
09/22/2023
16416
167279.04
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
09/27/2023
500000
6510386.94
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
10/02/2023
440752
4759774.3
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
10/03/2023
606221
6211506.9
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
10/05/2023
153027
1547102.97
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
10/24/2023
18261
164166.39
The securities included in Table I represent a maximum number of shares that may be sold to cover the reporting person's tax obligations when restricted stock units belonging to the reporting person are settled. The securities reported in Table I do not represent discretionary trades by the reporting person, and will be sold, or were sold, as applicable, for the limited purpose of satisfying tax withholding obligations. Table II does not include shares that were "net settled" by the Issuer in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units previously granted to the reporting person.
11/21/2023
02/17/2022
/s/ Eric Venker